X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1103) 1103
Book Review (207) 207
Publication (81) 81
Book Chapter (2) 2
Book / eBook (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1013) 1013
humans (993) 993
malaria (727) 727
female (684) 684
drug combinations (535) 535
antimalarials - therapeutic use (519) 519
sulfadoxine-pyrimethamine (447) 447
adult (431) 431
male (425) 425
pregnancy (375) 375
tropical medicine (374) 374
pyrimethamine - therapeutic use (365) 365
sulfadoxine - therapeutic use (365) 365
infectious diseases (355) 355
malaria, falciparum - drug therapy (347) 347
antimalarials - adverse effects (316) 316
child, preschool (305) 305
adolescent (302) 302
parasitic diseases (298) 298
antimalarials - administration & dosage (297) 297
infant (295) 295
child (263) 263
parasitology (262) 262
pyrimethamine - adverse effects (262) 262
sulfadoxine - adverse effects (262) 262
treatment outcome (261) 261
research (260) 260
children (258) 258
drug therapy, combination (257) 257
plasmodium falciparum (256) 256
antimalarials (252) 252
malaria - prevention & control (248) 248
drug resistance (240) 240
drug therapy (233) 233
animals (232) 232
plasmodium-falciparum malaria (225) 225
chloroquine (219) 219
pyrimethamine (218) 218
public, environmental & occupational health (203) 203
health aspects (201) 201
pyrimethamine - administration & dosage (201) 201
malaria - drug therapy (200) 200
sulfadoxine - administration & dosage (199) 199
artemisinins - therapeutic use (179) 179
efficacy (179) 179
middle aged (179) 179
young adult (177) 177
artesunate (175) 175
sulfadoxine (174) 174
pregnant women (172) 172
prevention (169) 169
abridged index medicus (159) 159
plasmodium falciparum - drug effects (159) 159
amodiaquine (153) 153
anemia (148) 148
vector-borne diseases (144) 144
plasmodium-falciparum (139) 139
medicine, general & internal (137) 137
public health (137) 137
resistance (136) 136
parasites (132) 132
africa (130) 130
artemether-lumefantrine (130) 130
intermittent preventive treatment (130) 130
clinical trials (127) 127
malaria, falciparum - epidemiology (127) 127
care and treatment (125) 125
infant, newborn (123) 123
infections (123) 123
artemisinins - administration & dosage (120) 120
malaria, falciparum - prevention & control (120) 120
mefloquine (120) 120
medicine (115) 115
pregnancy complications, parasitic - prevention & control (115) 115
chloroquine - therapeutic use (114) 114
risk factors (113) 113
infectious and parasitic diseases (112) 112
malaria, falciparum - parasitology (112) 112
arctic medicine. tropical medicine (109) 109
womens health (109) 109
dosage and administration (107) 107
women (107) 107
artemisinins - adverse effects (106) 106
malaria - epidemiology (104) 104
mortality (104) 104
analysis (102) 102
drugs (102) 102
drug administration schedule (101) 101
pharmacology & pharmacy (99) 99
drug dosages (98) 98
amodiaquine - therapeutic use (97) 97
medicine, preventive (95) 95
preventive health services (95) 95
studies (95) 95
research article (93) 93
sub-saharan africa (85) 85
placebo-controlled trial (84) 84
artemisinin (79) 79
medical research (79) 79
therapy (78) 78
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1063) 1063
French (19) 19
German (9) 9
Spanish (4) 4
Chinese (2) 2
Danish (2) 2
Japanese (2) 2
Swedish (2) 2
Dutch (1) 1
Italian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 2017, Volume 12, Issue 2, pp. e0168780 - e0168780
Mefloquine (MQ) has been used for the treatment of malaria since the mid-1980s, first as monotherapy or as fixed combination with sulfadoxine-pyrimethamine... 
RESISTANT FALCIPARUM-MALARIA | CLINICAL-TRIAL | PHARMACOKINETICS | PLASMODIUM-FALCIPARUM | ARTEMETHER-LUMEFANTRINE | DIHYDROARTEMISININ-PIPERAQUINE | MULTIDISCIPLINARY SCIENCES | ARTESUNATE-MEFLOQUINE | DOUBLE-BLIND | RANDOMIZED-TRIAL | COMBINATION | Outcome Assessment (Health Care) - methods | Nausea - chemically induced | Humans | Child, Preschool | Male | Sulfadoxine - adverse effects | Plasmodium falciparum - drug effects | Thailand | Dose-Response Relationship, Drug | Young Adult | Mefloquine - therapeutic use | Sulfadoxine - therapeutic use | Artesunate | Adult | Female | Plasmodium falciparum - physiology | Drug Therapy, Combination | Child | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Plasmodium vivax - drug effects | Pyrimethamine - adverse effects | Dizziness - chemically induced | Antimalarials - therapeutic use | Mefloquine - adverse effects | Host-Parasite Interactions - drug effects | Plasmodium vivax - physiology | Vomiting - chemically induced | Artemisinins - therapeutic use | Outcome Assessment (Health Care) - statistics & numerical data | Adolescent | Malaria - parasitology | Anorexia - chemically induced | Malaria - drug therapy | Artemisinins - adverse effects | Drug Combinations | Psychotic Disorders - etiology | Drugs | Complications and side effects | Mefloquine | Malaria | Adverse and side effects | Dosage and administration | Drug therapy | Risk factors | Vector-borne diseases | Multidrug resistance | Erythrocytes | Pyrimethamine | Clinical trials | Parasites | Drug resistance | Dosage | Patients | Medicine | Confidence intervals | Studies | Side effects | Vomiting | Antimalarial agents | New combinations | Sulfadoxine | Drug dosages | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2016, Volume 374, Issue 10, pp. 928 - 939
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2007, Volume 45, Issue 11, pp. 1453 - 1461
Background. Combination antimalarial therapy is advocated to improve treatment efficacy and limit selection of drug-resistant parasites. We compared the... 
Medical treatment failures | Relapse | Malaria | Vomiting | Articles and Commentaries | Antimalarials | Infections | Parasites | Parasitemia | Falciparum malaria | Fever | ANTIMALARIAL-DRUG | INFECTIOUS DISEASES | EFFICACY | COMBINATION THERAPY | MICROBIOLOGY | MEFLOQUINE | IMMUNOLOGY | CHLOROQUINE | CHILDREN | TRIAL | VIVAX MALARIA | TOLERABILITY | ARTESUNATE | Ethanolamines - adverse effects | Humans | Fluorenes - therapeutic use | Child, Preschool | Sulfadoxine - administration & dosage | Male | Sulfadoxine - adverse effects | Quinolines - administration & dosage | Ethanolamines - administration & dosage | Plasmodium falciparum | Pyrimethamine - administration & dosage | Sulfadoxine - therapeutic use | Amodiaquine - adverse effects | Female | Fluorenes - administration & dosage | Fluorenes - adverse effects | Amodiaquine - therapeutic use | Drug Therapy, Combination | Child | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Malaria, Falciparum - drug therapy | Pyrimethamine - adverse effects | Artemisinins - administration & dosage | Antimalarials - therapeutic use | Amodiaquine - administration & dosage | Animals | Artemisinins - therapeutic use | Burkina Faso | Antimalarials - administration & dosage | Ethanolamines - therapeutic use | Quinolines - therapeutic use | Artemisinins - adverse effects | Drug Combinations | Quinolines - adverse effects | Demographic aspects | Dosage and administration | Drug therapy, Combination | Drug therapy | Comparative analysis | Health aspects | Clinical trials | Bacteria | Nonsteroidal anti-inflammatory drugs | Index Medicus
Journal Article
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, ISSN 1469-493X, 2018, Volume 11, Issue 11, pp. CD011444 - CD011444
Background The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine for malaria for all... 
Abortion, Spontaneous [chemically induced; epidemiology] | HIV Infections [complications] | ANTIMALARIAL AGENTS | Africa South of the Sahara [epidemiology] | EFFICACY | LOW-BIRTH-WEIGHT | Humans | Trimethoprim | SULFADOXINE-PYRIMETHAMINE RESISTANCE | Thailand [epidemiology] | PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | Insecticide-Treated Bednets | Parasitemia [epidemiology] | Combination | PLASMODIUM-FALCIPARUM | INFANTS | Female | INFECTION | Pregnancy Complications, Parasitic [epidemiology; prevention & control] | Infant, Low Birth Weight | Mefloquine [adverse effects; therapeutic use] | Drug Therapy | RISK | Antimalarials [adverse effects; therapeutic use] | Dizziness [chemically induced; epidemiology] | Randomized Controlled Trials as Topic | Sulfadoxine [adverse effects; therapeutic use] | Pregnancy | Malaria [epidemiology; prevention & control] | HIV | Vomiting [chemically induced; epidemiology] | Sulfamethoxazole Drug Combination [therapeutic use] | Drug Combinations | Pyrimethamine [adverse effects; therapeutic use] | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | HIV Seronegativity | Placenta Diseases - epidemiology | Anemia - epidemiology | Pregnancy Complications, Infectious - epidemiology | Stillbirth | Antimalarials - therapeutic use | Parasitemia - drug therapy | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Placenta Diseases - parasitology | Mefloquine - adverse effects | Malaria - prevention & control | Vomiting - chemically induced | Mefloquine - therapeutic use | Sulfadoxine - therapeutic use | Pregnancy Complications, Infectious - prevention & control | Pregnancy Complications - chemically induced | Drug Therapy, Combination | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2010, Volume 54, Issue 5, pp. 1762 - 1768
Journal Article
Journal Article
AIDS, ISSN 0269-9370, 2014, Volume 28, Issue 18, pp. 2701 - 2709
Objective: Trimethoprim-sulfamethoxazole prophylaxis is recommended for HIV-exposed infants until breastfeeding ends and HIV infection has been excluded.... 
Dihydroartemsinin piperaquine | Trimethoprim sulfamethoxazole prophylaxis | Malaria chemoprevention | HIV-exposed uninfected infants | Sulfadoxine pyrimethamine | malaria chemoprevention | sulfadoxine pyrimethamine | INFECTIOUS DISEASES | FALCIPARUM-MALARIA | ANTIRETROVIRAL THERAPY | TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | dihydroartemsinin piperaquine | HIV-1-INFECTED ADULTS | trimethoprim sulfamethoxazole prophylaxis | VIROLOGY | COTRIMOXAZOLE PROPHYLAXIS | UNINFECTED CHILDREN | DIHYDROARTEMISININ-PIPERAQUINE | INSECTICIDE-TREATED BEDNETS | PLACEBO-CONTROLLED TRIAL | Antimalarials - adverse effects | Pyrimethamine - adverse effects | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Humans | Artemisinins - administration & dosage | Child, Preschool | Sulfadoxine - administration & dosage | Infant | Male | Treatment Outcome | Sulfadoxine - adverse effects | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Quinolines - administration & dosage | Chemoprevention - adverse effects | Malaria - prevention & control | Antimalarials - administration & dosage | Pyrimethamine - administration & dosage | Female | Uganda | Artemisinins - adverse effects | Drug Combinations | Quinolines - adverse effects | Chemoprevention - methods | Cohort Studies | Index Medicus | AIDS/HIV
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2015, Volume 59, Issue 7, pp. 4260 - 4271
Journal Article
Malaria Journal, ISSN 1475-2875, 2007, Volume 6, Issue 1, pp. 80 - 80
Background: In view of the high level of chloroquine resistance in many countries, WHO has recommended the use of combination therapy with artemisinin... 
SULFADOXINE/PYRIMETHAMINE | BENFLUMETOL | SULFADOXINE-PYRIMETHAMINE | ARTEMETHER-LUMEFANTRINE | AMODIAQUINE | RANDOMIZED-TRIAL | MEFLOQUINE | ARTESUNATE | PARASITOLOGY | TROPICAL MEDICINE | CHILDREN | Ethanolamines - adverse effects | Follow-Up Studies | Humans | Middle Aged | Fluorenes - therapeutic use | Child, Preschool | Sulfadoxine - administration & dosage | Infant | Sesquiterpenes - administration & dosage | Sulfadoxine - adverse effects | Plasmodium falciparum - drug effects | Ethanolamines - administration & dosage | Sesquiterpenes - adverse effects | Sesquiterpenes - therapeutic use | Mefloquine - therapeutic use | Pyrimethamine - administration & dosage | Sulfadoxine - therapeutic use | Mefloquine - administration & dosage | Adult | Amodiaquine - adverse effects | Fluorenes - administration & dosage | Fluorenes - adverse effects | Amodiaquine - therapeutic use | Drug Therapy, Combination | Child | Drug Resistance | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Malaria, Falciparum - drug therapy | Pyrimethamine - adverse effects | Artemisinins - administration & dosage | Treatment Outcome | Antimalarials - therapeutic use | Amodiaquine - administration & dosage | Mefloquine - adverse effects | Animals | Artemisinins - therapeutic use | Antimalarials - administration & dosage | Senegal | Adolescent | Ethanolamines - therapeutic use | Aged | Artemisinins - adverse effects | Drug Combinations | Antimalarials | Evaluation | Dosage and administration | Drug therapy, Combination | Malaria | Drug therapy | Index Medicus
Journal Article